Home > Pressrelease > U.S. Trauma Fixation Devices Market size to exceed $5Bn by 2032

U.S. Trauma Fixation Devices Market size to exceed $5Bn by 2032

  • Published Date: January 17, 2023

U.S. Trauma Fixation Devices Market size is projected to reach USD 5 billion by 2032, as per a new research report announced by Global Market Insights Inc.

Increasing incidences of road accidents and injuries in the U.S. are estimated to propel the demand for trauma fixation devices. Road accidents are among the leading causes of death in the country. Several schemes and trauma care programs have been implemented in the U.S. to minimize the impact of road traffic accidents. Hence, a growing focus on preventing and managing the impact of road accidents and other injuries will offer lucrative scope for trauma fixation device manufacturers.

Rise in injuries amongst children in the U.S. to propel the need for external fixators

External fixators play a key role in stabilizing damaged bones and catalyzing the entire recovery process. These types of devices are mainly used to perform procedures during the treatment of open fractures. Additionally, external fixators are also employed in case of fractures in children owing to the limitations and compatibility issues associated between internal fixators and developing bones. Unlike internal fixators, these devices reduce the risk of infection and any damage to the blood supply to fractured bones. They also offer more control over an injured area than non-invasive immobilization, such as casts and slings.

Recent breakthroughs in biomaterials and polymers to stir trauma fixation device adoption in the U.S.

The U.S. trauma fixation devices market revenue from other materials segment is poised to hit USD 693 million by the end of 2032. Other materials used in the manufacturing of trauma fixation devices include biomaterials, polymers, and biocompatible plastics among others. Recent advances in biomaterial technologies and 3D-printed fracture fixation devices will further gain traction. Moreover, manufacturers are increasingly using carbon polymer composites to design next-generation fracture fixation technologies for reducing implant failure and offering improved patient experience.

Browse key industry insights spread across 448 pages with 1029 market data tables & 19 figures & charts from the report, “U.S. Trauma Fixation Devices Market Size By Product (External Fixators {Unilateral & Bilateral, Circular, Hybrid}, Internal Fixator {Plates, Screws, Nails}), Material (Stainless Steel, Titanium), Site (Lower Extremities {Hip & Pelvic, Lower Leg, Knee, Foot & Ankle, Thigh}, Upper Extremities {Hand & Wrist, Shoulder, Elbow, Arm}), End-use (Hospitals, Ambulatory Surgical Centers, Orthopedic Centers), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:

Surge in arthritis-related disability to drive U.S. trauma fixation devices market demand for lower extremity fixation

Rising prevalence of bone degenerative diseases such as arthritis, and osteoporosis are fuelling the risk of injuries to reduced bone strength and increased friction between the joints. Degenerative bone disorders primarily occur in the elderly population due to the porosity of bones and aging but can also affect adults below the age of 60 years. According to the Centers for Disease Control & Prevention (CDC), arthritis is a leading cause of disability in the U.S. and is anticipated to account for 46% of the total number of adults with activity limitations by 2040.

Hefty investments in ASCs to boost adoption of trauma fixation devices in the U.S.

High patient preference for ASCs can be credited to their convenient and cost-effective service offerings. They effectively cater to low and middle-income groups with affordable treatment and facilitate flexible consultation, unlike hospitals. ASCs have gained significant popularity due to the rise in inpatient visits, allowing same-day surgery for patients. Due to high return on investment (ROI), lower staff turnover, improved operations, and exceptional patient satisfaction, these healthcare facilities are attracting significant investments.

Presence of advanced trauma centers to augment industry expansion in East North Central U.S.

East North Central U.S. trauma fixation devices market valuation to hit over USD 679 million by 2032. Large patient pool suffering from degenerative bone diseases will affect the business performance in the region. For instance, according to the Iowa Department of Public Health (IDPH), nearly 1 million Illinois women suffer from osteoporosis. Availability and accessibility to state-of-the-art trauma centers across Ohio, Michigan, and other East North Central states will pave the way for industry growth.

Rising count of strategic mergers and deals to boost U.S. trauma fixation devices industry development

Acumed LLC, Bioretec LTD, Integra LifeSciences, Smith & Nephew, CONMED Corporation, Stryker Corporation, Wright Medical Group N V, and Zimmer Biomet Holdings Inc. are some of the renowned companies in the U.S. trauma fixation devices market.

Authors: Sumant Ugalmugle, Rupali Swain